-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GTX-102 in Angelman Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GTX-102 in Angelman Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GTX-102 in Angelman Syndrome Drug Details: GTX-102 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Olezarsen Sodium in Familial Chylomicronemia (Type I Hyperlipoproteinemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Olezarsen Sodium in Familial Chylomicronemia (Type I Hyperlipoproteinemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Olezarsen Sodium in Familial Chylomicronemia (Type I...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Bepirovirsen Sodium in Hepatitis B
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Bepirovirsen Sodium in Hepatitis B report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Bepirovirsen Sodium in Hepatitis B Drug Details: IONIS-HBVRx (ISIS-HBVRx, ISIS-GSK3Rx)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Avicursen in Duchenne Muscular Dystrophy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Avicursen in Duchenne Muscular Dystrophy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Avicursen in Duchenne Muscular Dystrophy Drug Details: ATL-1102, (TV-1102, ISIS...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Danvatirsen Sodium in Myelodysplastic Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Danvatirsen Sodium in Myelodysplastic Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Danvatirsen Sodium in Myelodysplastic Syndrome Drug Details: Danvatirsen sodium (IONIS-STAT3)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Danvatirsen Sodium in Refractory Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Danvatirsen Sodium in Refractory Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Danvatirsen Sodium in Refractory Acute Myeloid Leukemia Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Danvatirsen Sodium in Relapsed Acute Myeloid Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Danvatirsen Sodium in Relapsed Acute Myeloid Leukemia report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Danvatirsen Sodium in Relapsed Acute Myeloid Leukemia Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pelacarsen Sodium in Cardiovascular Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pelacarsen Sodium in Cardiovascular Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pelacarsen Sodium in Cardiovascular Disease Drug Details: Pelacarsen sodium (IONIS-APOALRx)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pelacarsen Sodium in Aortic Valve Stenosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Pelacarsen Sodium in Aortic Valve Stenosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Pelacarsen Sodium in Aortic Valve Stenosis Drug Details: Pelacarsen...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trabedersen in Pancreatic Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trabedersen in Pancreatic Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trabedersen in Pancreatic Cancer Drug Details: Trabedersen (OT-101) is under development...